×
About 77,708 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  36,463 results

Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884167
Disease Markers; Abdelbasset WK, Nambi G et. al.

Feb 25th, 2021 - Sarcopenia is the most common feature of hepatic cirrhosis characterized by progressive loss of muscle mass and function and increases permanently the mortality and morbidity rates among those patients. The incidence of sarcopenia in cirrhotic pat...

Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced choles...
https://doi.org/10.1039/d0fo02910f
Food & Function; Zheng S, Cao P et. al.

Feb 23rd, 2021 - Cholestasis can induce liver fibrosis and cirrhosis. Apigenin has anti-oxidant and anti-inflammatory effects. Herein, we determined whether apigenin can protect mice against cholestasis. In vitro, apigenin protected TFK-1 cells (a human bile duct ...

Deep stool microbiome analysis in cirrhosis reveals an association between short-chain ...
https://doi.org/10.1016/j.aohep.2021.100333
Annals of Hepatology; Bloom PP, Luévano JM et. al.

Feb 23rd, 2021 - Hepatic encephalopathy (HE) is a complication of cirrhosis linked to the microbiome. We aimed to characterize the fecal microbiome of patients with prior and future overt HE, and explore the relationship between fecal species, short-chain fatty ac...

see more →

Guidelines  113 results

Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
https://doi.org/10.1053/j.gastro.2020.09.065
Gastroenterology Rockey DC, Friedman SL

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.10.034
Clinical Gastroenterology and Hepatology : the Official C... Patton H, Heimbach J et. al.

Jan 4th, 2021 - AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.|2021|Patton H,Heimbach J,McCullough A,|

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.11.027
Clinical Gastroenterology and Hepatology : the Official C... Tandon P, Walling A et. al.

Nov 22nd, 2020 - Care with palliative care principles (aka Palliative Care, PC) is an approach to care that focuses on improving the quality of life of patients and their caregivers who are facing life-limiting illness. It encompasses the assessment and management...

see more →

Drugs  879 results see all →

Clinicaltrials.gov  38,517 results

Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884167
Disease Markers; Abdelbasset WK, Nambi G et. al.

Feb 25th, 2021 - Sarcopenia is the most common feature of hepatic cirrhosis characterized by progressive loss of muscle mass and function and increases permanently the mortality and morbidity rates among those patients. The incidence of sarcopenia in cirrhotic pat...

Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced choles...
https://doi.org/10.1039/d0fo02910f
Food & Function; Zheng S, Cao P et. al.

Feb 23rd, 2021 - Cholestasis can induce liver fibrosis and cirrhosis. Apigenin has anti-oxidant and anti-inflammatory effects. Herein, we determined whether apigenin can protect mice against cholestasis. In vitro, apigenin protected TFK-1 cells (a human bile duct ...

Deep stool microbiome analysis in cirrhosis reveals an association between short-chain ...
https://doi.org/10.1016/j.aohep.2021.100333
Annals of Hepatology; Bloom PP, Luévano JM et. al.

Feb 23rd, 2021 - Hepatic encephalopathy (HE) is a complication of cirrhosis linked to the microbiome. We aimed to characterize the fecal microbiome of patients with prior and future overt HE, and explore the relationship between fecal species, short-chain fatty ac...

see more →

News  1,659 results

Algorithm Uses Routine Blood Tests to Detect Advanced Liver Disease
https://www.medscape.com/viewarticle/946198

Feb 22nd, 2021 - NEW YORK (Reuters Health) - It may be possible to pick up occult liver cirrhosis with an algorithm that uses data from routine blood tests, according to new research. The CIRRUS algorithm can find "a fingerprint for cirrhosis in the common blood t...

AGA Clinical Practice Update: Bariatric Surgery in Patients With Cirrhosis
https://www.medscape.com/viewarticle/945465

Feb 7th, 2021 - Obesity, a risk factor for nonalcoholic fatty liver disease (NAFLD) and a prevalent comorbidity among people with cirrhosis of all etiologies, is associated with a number of untoward health outcomes, and weight loss is an important goal, according...

Rifaximin May Prevent Hepatic Encephalopathy After TIPS Placement for Cirrhosis
https://www.medscape.com/viewarticle/945312

Feb 4th, 2021 - NEW YORK (Reuters Health) - The antibiotic rifaximin given before and after transjugular intrahepatic portosystemic shunt (TIPS) placement helped prevent hepatic encephalopathy (HE) in a placebo-controlled trial. "TIPS is a very effective treatmen...

Widespread Liver Disease Missed in Patients With Type 2 Diabetes
https://www.medscape.com/viewarticle/944609

Jan 24th, 2021 - Mounting evidence of strikingly high prevalence rates of fatty liver disease, advanced fibrosis, and cirrhosis among patients with type 2 diabetes has led to calls for heightened awareness and screening to identify these patients and target treatm...

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

see more →

Patient Education  77 results see all →